HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.

Abstract
Certain bispecific single-chain antibody constructs exhibit an extraordinary potency for polyclonal T cell engagement and target cell lysis. Here we studied the structural basis for this potency, using laser scanning confocal microscopy. Cytolytic human T cell synapses could be triggered either by addition of a specific peptide antigen or an Ep-CAM-/CD3-bispecific T cell engager (BiTE). Both kinds of synapses showed a comparable distribution of all protein markers investigated. Two other BiTEs constructed from different Ep-CAM-specific antibodies gave similar results. BiTEs could also induce lytic synapses between human T cells and a MHC class I-negative, Ep-CAM cDNA-transfected cell line resulting in potent target cell lysis. This shows that certain T cell recognition molecules on target cells are dispensable for synapse formation and BiTE activity, and suggests that BiTE-activated polyclonal T cells may ignore major immune evasion mechanisms of tumor cells in vivo, such as loss of MHC class I expression.
AuthorsSonja Offner, Robert Hofmeister, Andrea Romaniuk, Peter Kufer, Patrick A Baeuerle
JournalMolecular immunology (Mol Immunol) Vol. 43 Issue 6 Pg. 763-71 (Feb 2006) ISSN: 0161-5890 [Print] England
PMID16360021 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bispecific
  • Epitopes, T-Lymphocyte
  • Histocompatibility Antigens Class I
Topics
  • Antibodies, Bispecific (chemistry, immunology)
  • Cell Communication (immunology)
  • Cell Line, Tumor
  • Coculture Techniques
  • Epitopes, T-Lymphocyte (immunology)
  • Histocompatibility Antigens Class I
  • Humans
  • Lymphocyte Activation (immunology)
  • Microscopy, Confocal
  • Neoplasms (immunology, pathology)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Tumor Escape

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: